TAMARA MASON: Open Payments
NPI 1407330996 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 20 payments from 12 companies in 2025. Trend: 2023 $509 · 2024 $661 · 2025 $468
Food & beverage: $314Education: $154
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Janssen Biotech, Inc. | 3 | $83 |
| Galderma Laboratories, L.P. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| ABBVIE INC. | 2 | $33 |
| Lilly USA, LLC | 1 | $26 |
| SpringWorks Therapeutics, Inc. | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| Amgen Inc. | 1 | $20 |
| UCB, Inc. | 1 | $18 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, EBGLYSS, GOMEKLI, COSENTYX, Cabtreo, Otezla.
Industry payments across WY — which companies pay providers there.
